president Francisco Sagasti Announcing the signing of an agreement with Chinese pharmaceutical company Sinopharm for the supply of 38 million doses. Vaccine Against COVID-19 In a message to the nation, the president announced that the first million vaccines will arrive in January. Two times required
Read Also
- Nastya Kamenskikh underwear trimmed a rounded shape Jul 17, 2020
- Kanye West told how much money he has May 7, 2020
- Why the bike JUMP Uber have deserted the streets of paris ? Jun 17, 2020
- Regulators propose joint guidance on managing third-party risk Jul 13, 2021
- Zodiac Prediction April 14, 2021: Aries, Taurus, and Gemini, Don’t Trust Your Partner Apr 13, 2021
- Charles Leclerc will start from pole at the Formula 1 Monaco Grand Prix: time, TV and qualifying May 29, 2022
- USA: for the first time in 34 years, vinyl sales overtake CDs Sep 13, 2020
This is the first agreement the Peruvian state has signed with a pharmaceutical company for the purchase of the vaccine.
Sinopharm vaccine is 79% effective and is “Conditional” for marketing from the Chinese health agency, Sinopharm is the first Chinese pharmaceutical group to report data on the effectiveness of vaccines in their preparations.
United Arab Emirates and Egypt It is the other two countries that have announced they have approved a vaccine made by Sinopharm with the Beijing Institute of Biological Products.
The efficacy rate of Sinopharm’s vaccine is lower than what competitors Pfizer / BioNTech (95%) and Moderna claim (94.1%).
Peru is part of the Phase III clinical trial of the Sinopharm vaccine. Thousands of people volunteer and receive both of these vaccines under the supervision of the Sinopharm. Cayetano Heredia Peruvian University (UPCH) and National University of San Marcos (UNMSM)
